“I’m very confident that this year we’ll consummate some more deals,” said Shire CEO Angus Russell at a lunch announcing the group’s full-ye...

Over the weekend Shire announced approval of Vyvanse , its next-generation ADHD drug licensed from soon-to-be-acquired partner New River . O...

Once again, ally turns to buy . Eager to land 100% of the two companies' profits from the soon-to-be-approved ADHD drug Vyvanse (former...